Document is current
Any future updates will be listed below
-
Authors
Alexandrou, Sarah
Lee, Christine S.
Fernandez, Kristine J.
Wiharja, Celine E.
Eshraghi, Leila
Reeves, John
Reed, Daniel A.
Portman, Neil
Phan, Zoe
Milioli, Heloisa H.
Nikolic, Iva
Cadell, Antonia L.
Croucher, David R.
Simpson, Kaylene J.
Lim, Elgene
Hickey, Theresa E.
Millar, Ewan K. A.
Alves, Carla L.
Ditzel, Henrik J.
Caldon, C. Elizabeth
-
Funding
Funding for this research was provided by:
Australian Government Research Training Program Scholarship
Estée Lauder Breast Cancer Award
Australian Cancer Research Foundation
National Breast Cancer Foundation IIRS grant (2022/IIRS070)
Lysia O’Keefe Fellowship
Mavis Robertson Fellowship
Cancer Institute NSW Fellowship (CDF1071)
- License Information
-
More Information
Article History
Received: 15 April 2025
Accepted: 3 July 2025
First Online: 19 August 2025
Declarations
:
: All animal work was performed in compliance with the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes (National Health and Medical Research Council). The protocol and study end points were approved by the St. Vincent’s Health Precinct and GIMR Animal Ethics Committee (ARA 21/09).
: N/A.
: E. L provides advisory board services to AstraZeneca, Gilead, Lilly, MDS, Novartis, Pfizer, Roche, and received royalties from Walter and Eliza Hall Institute.
